A synthetic peptide AWRK6 ameliorates metabolic associated fatty liver disease: involvement of lipid and glucose homeostasis
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry
Reference29 articles.
1. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018
2. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement;Eslam;Journal of Hepatology,2020
3. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease;Eslam;Hepatology International,2020
4. Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa;Shiha;Lancet Gastroenterol Hepatol,2021
5. The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease;Mendez-Sanchez;Lancet Gastroenterol Hepatol,2021
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging production techniques and potential health promoting properties of plant and animal protein-derived bioactive peptides;Critical Reviews in Food Science and Nutrition;2024-08-29
2. Current strategies for nonalcoholic fatty liver disease treatment (Review);International Journal of Molecular Medicine;2024-08-08
3. Pipeline of New Drug Treatment for Non-alcoholic Fatty Liver Disease/Metabolic Dysfunction-associated Steatotic Liver Disease;Journal of Clinical and Translational Hepatology;2024-07-31
4. The Peptide AWRK6 Alleviates Lipid Accumulation in Hepatocytes by Inhibiting miR-5100 Targeting G6PC;International Journal of Molecular Sciences;2023-11-09
5. Protein kinases: The key contributors in pathogenesis and treatment of nonalcoholic fatty liver disease-derived hepatocellular carcinoma;Metabolism;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3